Aratana Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 26
Quantité totale incluant filiales 32 (+ 6 pour les filiales)
Rang # Quantité totale PI 56 691
Note d'activité PI 1,8/5.0    10
Rang # Activité PI 90 685

Brevets

Marques

17 0
5 0
4 0
0
 
Dernier brevet 2025 - Compositions of grapiprant and m...
Premier brevet 2009 - Monoclonal antibodies

Filiales

2 subsidiaries with IP (6 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2024 Invention Compositions of grapiprant and methods for using the same. The present disclosure provides a met...
Invention Eye drop composition. The present invention relates to an eye-drop composition comprising 2-amin...
2021 Invention Compositions of grapiprant and methods for using the same. The present disclosure provides a meth...
Invention Eye drop composition. The present invention relates to an eye-drop composition comprising 2-amino...
2017 Invention Compositions and methods for chronic use of a weight-gaining compound. Provided herein is a metho...
2016 Invention Monoclonal antibodies directed to cd20. The invention provides antibody to canine or feline or e...
2015 Invention Crystalline forms of grapiprant. The present disclosure provides a crystalline form of grap...
Invention Crystalline forms of grapiprant. The present disclosure provides a crystalline form of grapiprant...
2014 Invention Monoclonal antibodies directed to cd52. The invention provides antibody to canine or feline or e...
2013 Invention Compositions and methods of use of an inappetance-controlling compound. The invention provides fo...
Invention Antibody constant domain regions and uses thereof. The invention provides recombinant protein (e...
Invention Monoclonal antibodies. The invention provides heterochimeric antibodies and/or fragments thereof...
2011 Invention Method for preparing cyclopropane derivatives. The present invention relates to the preparation o...
Invention Method for preparing cyclopropane derivatives. The present invention relates to the prepara...
Invention Monoclonal antibodies directed to cd20. The invention provides antibody to canine or feline or eq...
Invention Monoclonal antibodies directed to cd52. The invention provides antibody to canine or feline or eq...
2010 Invention Antibody constant domain regions and uses thereof. The invention provides recombinant protein (e....
2009 Invention Monoclonal antibodies. The invention provides heterochimeric antibodies and/or fragments thereof ...